Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Brain disorders resulting from inborn metabolic errors, primarily from enzymatic defects which lead to substrate accumulation, product reduction, or increase in toxic metabolites through alternate pathways. The majority of these conditions are familial, however spontaneous mutation may also occur in utero.
Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.
Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.
Any of various diseases affecting the white matter of the central nervous system.
Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function.
Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Specialized non-fenestrated tightly-joined ENDOTHELIAL CELLS with TIGHT JUNCTIONS that form a transport barrier for certain substances between the cerebral capillaries and the BRAIN tissue.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
Self-renewing cells that generate the main phenotypes of the nervous system in both the embryo and adult. Neural stem cells are precursors to both NEURONS and NEUROGLIA.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Imaging techniques used to colocalize sites of brain functions or physiological activity with brain structures.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling.
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING).
Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
The part of the brain that connects the CEREBRAL HEMISPHERES with the SPINAL CORD. It consists of the MESENCEPHALON; PONS; and MEDULLA OBLONGATA.
Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.
A circumscribed collection of purulent exudate in the brain, due to bacterial and other infections. The majority are caused by spread of infected material from a focus of suppuration elsewhere in the body, notably the PARANASAL SINUSES, middle ear (see EAR, MIDDLE); HEART (see also ENDOCARDITIS, BACTERIAL), and LUNG. Penetrating CRANIOCEREBRAL TRAUMA and NEUROSURGICAL PROCEDURES may also be associated with this condition. Clinical manifestations include HEADACHE; SEIZURES; focal neurologic deficits; and alterations of consciousness. (Adams et al., Principles of Neurology, 6th ed, pp712-6)
A reduction in brain oxygen supply due to ANOXEMIA (a reduced amount of oxygen being carried in the blood by HEMOGLOBIN), or to a restriction of the blood supply to the brain, or both. Severe hypoxia is referred to as anoxia, and is a relatively common cause of injury to the central nervous system. Prolonged brain anoxia may lead to BRAIN DEATH or a PERSISTENT VEGETATIVE STATE. Histologically, this condition is characterized by neuronal loss which is most prominent in the HIPPOCAMPUS; GLOBUS PALLIDUS; CEREBELLUM; and inferior olives.
The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulchi. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions.
A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Proton MR spectroscopy of Sjogren-Larsson's syndrome. (1/60)

We performed single-voxel proton MR spectroscopy (1H-MRS) in two children with Sjogren-Larsson's syndrome (SLS). Both patients showed two abnormal spectral peaks at 1.3 ppm and 0.9 ppm that were obtained with short echo times. These two abnormal spectral peaks were seen in high-intensity areas on T2-weighted images and also in basal ganglia of normal intensities. 1H-MRS may be useful for establishing the diagnosis and investigating the natural history of SLS, and for evaluating the efficacy of therapeutic approaches to SLS.  (+info)

Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) (2/60)

Congenital disorders of glycosylation (CDGs) are metabolic deficiencies in glycoprotein biosynthesis that usually cause severe mental and psychomotor retardation. Different forms of CDGs can be recognized by altered isoelectric focusing (IEF) patterns of serum transferrin (Tf). Two patients with these symptoms and similar abnormal Tf IEF patterns were analyzed by metabolic labeling of fibroblasts with inverted question mark2-(3)Hmannose. The patients produced a truncated dolichol-linked precursor oligosaccharide with 5 mannose residues, instead of the normal precursor with 9 mannose residues. Addition of 250 microM mannose to the culture medium corrected the size of the truncated oligosaccharide. Microsomes from fibroblasts of these patients were approximately 95% deficient in dolichol-phosphate-mannose (Dol-P-Man) synthase activity, with an apparent K(m) for GDP-Man approximately 6-fold higher than normal. DPM1, the gene coding for the catalytic subunit of Dol-P-Man synthase, was altered in both patients. One patient had a point mutation, C(274)G, causing an R(92)G change in the coding sequence. The other patient also had the C(274)G mutation and a 13-bp deletion that presumably resulted in an unstable transcript. Defects in DPM1 define a new glycosylation disorder, CDG-Ie.  (+info)

Extensive intracranial xanthoma associated with type II hyperlipidemia. (3/60)

Xanthomas are associated with a spectrum of medical conditions, most commonly disorders of lipid storage and lipid metabolism. They occur primarily in the subcutaneous tissues, especially along the Achilles tendon and the extensor tendons of the hands. Intracranial xanthomas are extremely rare. We present a case of an extensive xanthoma of the temporal bone in a patient with hyperlipidemia.  (+info)

Mutation analysis in glutaric aciduria type I. (4/60)

Glutaric aciduria type 1 (GA1), resulting from the genetic deficiency of glutaryl-CoA dehydrogenase (GDH), is a relatively common cause of acute metabolic brain damage in infants. Encephalopathic crises may be prevented by carnitine supplementation and diet, but diagnosis can be difficult as some patients do not show the typical excretion of large amounts of glutaric and 3-hydroxyglutaric acids in the urine. We present a rapid and efficient denaturing gradient gel electrophoresis (DGGE) method for the identification of mutations in the glutaryl-CoA dehydrogenase (GCDH) gene that may be used for the molecular diagnosis of GA1 in a routine setting. Using this technique, we identified mutations on both alleles in 48 patients with confirmed GDH deficiency, while no mutations were detected in other patients with clinical suspicion of GA1 but normal enzyme studies. There was a total of 38 different mutations; 27 mutations were found in single patients only, and 21 mutations have not been previously reported. Fourteen mutations involved hypermutable CpG sites. The commonest GA1 mutation in Europeans is R402W, which accounts for almost 40% of alleles in patients of German origin. GCDH gene haplotypes were determined through the analysis of polymorphic markers in all families, and three CpG mutations were associated with different haplotypes, possibly reflecting independent recurrence. The high sensitivity of the DGGE method allows the rapid and cost efficient diagnosis of GA1 in instances where enzyme analyses are not available or feasible, despite the marked heterogeneity of the disease.  (+info)

Abnormal vertical optokinetic nystagmus in infants and children. (5/60)

AIMS: To determine if testing vertical optokinetic nystagmus (VOKN) has a role in the clinical assessment of infants and children. METHODS: A large field projection system was developed with which optokinetic nystagmus (OKN) could be stimulated in any direction. Gross abnormalities in the response were detected simply by observation. RESULTS: VOKN was tested in 144 children using this OKN projection system. 26 of these children had abnormal VOKN; 13 had a vertical saccade initiation failure "ocular motor apraxia" (in either direction, up/down, or in both) and 13 had absent VOKN (in either direction, up/down, or in both). Nine of the children with an up and/or down vertical saccade initiation failure (VSIF) had a neurometabolic disease (two had Niemann-Pick disease type C, five had Gaucher disease type III, one had Gaucher disease type II, and one had Gaucher disease type I). Five children with a VSIF had an abnormality identified by a magnetic resonance imaging (MRI) scan of the brain. In two of these children there was a focal lesion of the rostral midbrain. In 11 of the children with absent up and/or down VOKN an MRI scan revealed an abnormality. This involved the brainstem and/or the cerebellum in 10. Absent up and/or down VOKN was found in association with Joubert syndrome, Leigh disease, and cerebral palsy. CONCLUSION: VOKN testing has a useful role in detecting neurological abnormalities in infants and children. Detection of abnormal VOKN should indicate further investigations for a neurometabolic disease or an abnormality involving the cortex, brainstem, and/or cerebellum. Abnormal VOKN but normal horizontal OKN is highly suggestive of a rostral midbrain lesion.  (+info)

Cytochrome c oxidase-deficient patients have distinct subunit assembly profiles. (6/60)

Cytochrome c oxidase (COX) deficiency is the most common respiratory chain defect in childhood and is clinically heterogeneous. We report a study of six patients with COX deficiencies. Two of the patients had as yet undefined defects, three patients had Surf-1 mutations, and one patient had a 15-base pair deletion in the COX III subunit. We show that quantitative measurements of steady-state levels of subunits by monoclonal antibody reactivity, when used in combination with a discontinuous sucrose gradient methods, provide an improved diagnosis of COX deficiencies by distinguishing between kinetic, stability, and assembly defects. The two mutants of undefined etiology had a full complement of subunits with one stable and the other partially unstable to detergent solubilization. Both are likely to carry mutations in nuclear-encoded subunits of the complex. The three Surf-1 mutants and the COX III mutant each had reduced steady-state levels of subunits but variable associations of the residual subunits. This information, as well as aiding in diagnosis, helps in understanding the genotype-phenotype relationships of COX deficiencies and provides insight into the mechanism of assembly of the enzyme complex.  (+info)

MR brain imaging of fucosidosis type I. (7/60)

SUMMARY: Fucosidosis is a rare autosomal recessive lysosomal storage disease with the main clinical findings of progressive neuromotor deterioration, seizures, coarse facial features, dysostosis multiplex, angiokeratoma corporis diffusum, visceromegaly, recurrent respiratory infections, and growth retardation. Fucosidosis type I rapidly evolves toward a progressive neurologic deterioration and death. We report MR imaging findings of the brain of three patients with fucosidosis type I, including previously unreported findings, to expand the knowledge of the neuroradiologic spectrum of the disease.  (+info)

A new neurological entity manifesting as involuntary movements and dysarthria with possible abnormal copper metabolism. (8/60)

A few patients with an affected CNS involving abnormalities in copper metabolism have been described that do not fit any known nosological entities such as Wilson's disease or Menkes' disease. Three sporadic patients (two men and one woman) were examined with involuntary movements and dysarthria associated with abnormal concentrations of serum copper, serum ceruloplasmin, and urinary copper excretion. The onset of neurological symptoms occurred at the age of 15 to 17 years. The common clinical symptoms were involuntary movements and dysarthria. The involuntary movements included dystonia in the neck, myoclonus in the shoulder, athetosis in the neck, and rapid orobuccal movements. The dysarthria consisted of unclear, slow, and stuttering speech. Two of the three patients did not have dementia. A cousin of the female patient had been diagnosed as having Wilson's disease and had died of liver cirrhosis. Laboratory findings showed a mild reduction in serum copper and ceruloplasmin concentrations, whereas urinary copper excretion was significantly reduced in all three patients. Two of the three patients showed a high signal intensity in the basal ganglia on T2 weighted brain MRI. In conclusion, the unique findings of involuntary movements, dysarthria, and abnormal serum copper and urinary copper concentrations suggest that the three patients may constitute a new clinical entity that is distinct from either Wilson's or Menkes disease.  (+info)

Brain diseases, also known as neurological disorders, refer to a wide range of conditions that affect the brain and nervous system. These diseases can be caused by various factors such as genetics, infections, injuries, degeneration, or structural abnormalities. They can affect different parts of the brain, leading to a variety of symptoms and complications.

Some examples of brain diseases include:

1. Alzheimer's disease - a progressive degenerative disorder that affects memory and cognitive function.
2. Parkinson's disease - a movement disorder characterized by tremors, stiffness, and difficulty with coordination and balance.
3. Multiple sclerosis - a chronic autoimmune disease that affects the nervous system and can cause a range of symptoms such as vision loss, muscle weakness, and cognitive impairment.
4. Epilepsy - a neurological disorder characterized by recurrent seizures.
5. Brain tumors - abnormal growths in the brain that can be benign or malignant.
6. Stroke - a sudden interruption of blood flow to the brain, which can cause paralysis, speech difficulties, and other neurological symptoms.
7. Meningitis - an infection of the membranes surrounding the brain and spinal cord.
8. Encephalitis - an inflammation of the brain that can be caused by viruses, bacteria, or autoimmune disorders.
9. Huntington's disease - a genetic disorder that affects muscle coordination, cognitive function, and mental health.
10. Migraine - a neurological condition characterized by severe headaches, often accompanied by nausea, vomiting, and sensitivity to light and sound.

Brain diseases can range from mild to severe and may be treatable or incurable. They can affect people of all ages and backgrounds, and early diagnosis and treatment are essential for improving outcomes and quality of life.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

Metabolic brain diseases are a group of disorders caused by genetic defects that affect the body's metabolism and result in abnormal accumulation of harmful substances in the brain. These conditions are present at birth (inborn) or develop during infancy or early childhood. Examples of metabolic brain diseases that are present at birth include:

1. Phenylketonuria (PKU): A disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which leads to an accumulation of phenylalanine in the brain and can cause intellectual disability, seizures, and behavioral problems if left untreated.
2. Maple syrup urine disease (MSUD): A disorder caused by a deficiency of the enzyme branched-chain ketoacid dehydrogenase, which leads to an accumulation of branched-chain amino acids in the body and can cause intellectual disability, seizures, and metabolic crisis if left untreated.
3. Urea cycle disorders: A group of disorders caused by defects in enzymes that help remove ammonia from the body. Accumulation of ammonia in the blood can lead to brain damage, coma, or death if not treated promptly.
4. Organic acidemias: A group of disorders caused by defects in enzymes that help break down certain amino acids and other organic compounds. These conditions can cause metabolic acidosis, seizures, and developmental delays if left untreated.

Early diagnosis and treatment of these conditions are crucial to prevent irreversible brain damage and other complications. Treatment typically involves dietary restrictions, supplements, and medications to manage the underlying metabolic imbalance. In some cases, enzyme replacement therapy or liver transplantation may be necessary.

Encephalitis is defined as inflammation of the brain parenchyma, which is often caused by viral infections but can also be due to bacterial, fungal, or parasitic infections, autoimmune disorders, or exposure to toxins. The infection or inflammation can cause various symptoms such as headache, fever, confusion, seizures, and altered consciousness, ranging from mild symptoms to severe cases that can lead to brain damage, long-term disabilities, or even death.

The diagnosis of encephalitis typically involves a combination of clinical evaluation, imaging studies (such as MRI or CT scans), and laboratory tests (such as cerebrospinal fluid analysis). Treatment may include antiviral medications, corticosteroids, immunoglobulins, and supportive care to manage symptoms and prevent complications.

Medical Definition:

Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic imaging technique that uses a strong magnetic field and radio waves to create detailed cross-sectional or three-dimensional images of the internal structures of the body. The patient lies within a large, cylindrical magnet, and the scanner detects changes in the direction of the magnetic field caused by protons in the body. These changes are then converted into detailed images that help medical professionals to diagnose and monitor various medical conditions, such as tumors, injuries, or diseases affecting the brain, spinal cord, heart, blood vessels, joints, and other internal organs. MRI does not use radiation like computed tomography (CT) scans.

Mucopolysaccharidosis I (MPS I) is a rare genetic disorder caused by the deficiency of an enzyme called alpha-L-iduronidase. This enzyme is responsible for breaking down complex sugars called glycosaminoglycans (GAGs), also known as mucopolysaccharides, in the body.

When the enzyme is deficient, GAGs accumulate in various tissues and organs, leading to a range of symptoms that can affect different parts of the body, including the skeletal system, heart, respiratory system, eyes, and central nervous system. There are three subtypes of MPS I: Hurler syndrome (the most severe form), Hurler-Scheie syndrome (an intermediate form), and Scheie syndrome (the least severe form).

The symptoms and severity of MPS I can vary widely depending on the specific subtype, with Hurler syndrome typically causing more significant health problems and a shorter life expectancy than the other two forms. Treatment options for MPS I include enzyme replacement therapy, bone marrow transplantation, and various supportive therapies to manage symptoms and improve quality of life.

Leukoencephalopathies are a group of medical conditions that primarily affect the white matter of the brain, which consists mainly of nerve fibers covered by myelin sheaths. These conditions are characterized by abnormalities in the structure and function of the white matter, leading to various neurological symptoms such as cognitive decline, motor impairment, seizures, and behavioral changes.

The term "leukoencephalopathy" is derived from two Greek words: "leukos," meaning white, and "enkephalos," meaning brain. The suffix "-pathy" refers to a disease or suffering. Therefore, leukoencephalopathies refer specifically to diseases that affect the white matter of the brain.

There are various types of leukoencephalopathies, including genetic, metabolic, infectious, toxic, and immune-mediated forms. Some examples include multiple sclerosis, adrenoleukodystrophy, Alexander disease, Canavan disease, and Marchiafava-Bignami disease. The diagnosis of leukoencephalopathies typically involves a combination of clinical evaluation, imaging studies such as MRI, and sometimes genetic or laboratory testing to identify the underlying cause. Treatment depends on the specific type and severity of the condition and may include medications, dietary modifications, physical therapy, or supportive care.

Metabolic brain diseases refer to a group of conditions that are caused by disruptions in the body's metabolic processes, which affect the brain. These disorders can be inherited or acquired and can result from problems with the way the body produces, breaks down, or uses energy and nutrients.

Examples of metabolic brain diseases include:

1. Mitochondrial encephalomyopathies: These are a group of genetic disorders that affect the mitochondria, which are the energy-producing structures in cells. When the mitochondria don't function properly, it can lead to muscle weakness, neurological problems, and developmental delays.
2. Leukodystrophies: These are a group of genetic disorders that affect the white matter of the brain, which is made up of nerve fibers covered in myelin, a fatty substance that insulates the fibers and helps them transmit signals. When the myelin breaks down or is not produced properly, it can lead to cognitive decline, motor problems, and other neurological symptoms.
3. Lysosomal storage disorders: These are genetic disorders that affect the lysosomes, which are structures in cells that break down waste products and recycle cellular materials. When the lysosomes don't function properly, it can lead to the accumulation of waste products in cells, including brain cells, causing damage and neurological symptoms.
4. Maple syrup urine disease: This is a genetic disorder that affects the way the body breaks down certain amino acids, leading to a buildup of toxic levels of these substances in the blood and urine. If left untreated, it can cause brain damage, developmental delays, and other neurological problems.
5. Homocystinuria: This is a genetic disorder that affects the way the body processes an amino acid called methionine, leading to a buildup of homocysteine in the blood. High levels of homocysteine can cause damage to the blood vessels and lead to neurological problems, including seizures, developmental delays, and cognitive decline.

Treatment for metabolic brain diseases may involve dietary changes, supplements, medications, or other therapies aimed at managing symptoms and preventing further damage to the brain. In some cases, a stem cell transplant may be recommended as a treatment option.

Brain chemistry refers to the chemical processes that occur within the brain, particularly those involving neurotransmitters, neuromodulators, and neuropeptides. These chemicals are responsible for transmitting signals between neurons (nerve cells) in the brain, allowing for various cognitive, emotional, and physical functions.

Neurotransmitters are chemical messengers that transmit signals across the synapse (the tiny gap between two neurons). Examples of neurotransmitters include dopamine, serotonin, norepinephrine, GABA (gamma-aminobutyric acid), and glutamate. Each neurotransmitter has a specific role in brain function, such as regulating mood, motivation, attention, memory, and movement.

Neuromodulators are chemicals that modify the effects of neurotransmitters on neurons. They can enhance or inhibit the transmission of signals between neurons, thereby modulating brain activity. Examples of neuromodulators include acetylcholine, histamine, and substance P.

Neuropeptides are small protein-like molecules that act as neurotransmitters or neuromodulators. They play a role in various physiological functions, such as pain perception, stress response, and reward processing. Examples of neuropeptides include endorphins, enkephalins, and oxytocin.

Abnormalities in brain chemistry can lead to various neurological and psychiatric conditions, such as depression, anxiety disorders, schizophrenia, Parkinson's disease, and Alzheimer's disease. Understanding brain chemistry is crucial for developing effective treatments for these conditions.

Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. It's the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.

The early signs of the disease include forgetting recent events or conversations. As the disease progresses, a person with Alzheimer's disease will develop severe memory impairment and lose the ability to carry out everyday tasks.

Currently, there's no cure for Alzheimer's disease. However, treatments can temporarily slow the worsening of dementia symptoms and improve quality of life.

The Blood-Brain Barrier (BBB) is a highly specialized, selective interface between the central nervous system (CNS) and the circulating blood. It is formed by unique endothelial cells that line the brain's capillaries, along with tight junctions, astrocytic foot processes, and pericytes, which together restrict the passage of substances from the bloodstream into the CNS. This barrier serves to protect the brain from harmful agents and maintain a stable environment for proper neural function. However, it also poses a challenge in delivering therapeutics to the CNS, as most large and hydrophilic molecules cannot cross the BBB.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

A brain injury is defined as damage to the brain that occurs following an external force or trauma, such as a blow to the head, a fall, or a motor vehicle accident. Brain injuries can also result from internal conditions, such as lack of oxygen or a stroke. There are two main types of brain injuries: traumatic and acquired.

Traumatic brain injury (TBI) is caused by an external force that results in the brain moving within the skull or the skull being fractured. Mild TBIs may result in temporary symptoms such as headaches, confusion, and memory loss, while severe TBIs can cause long-term complications, including physical, cognitive, and emotional impairments.

Acquired brain injury (ABI) is any injury to the brain that occurs after birth and is not hereditary, congenital, or degenerative. ABIs are often caused by medical conditions such as strokes, tumors, anoxia (lack of oxygen), or infections.

Both TBIs and ABIs can range from mild to severe and may result in a variety of physical, cognitive, and emotional symptoms that can impact a person's ability to perform daily activities and function independently. Treatment for brain injuries typically involves a multidisciplinary approach, including medical management, rehabilitation, and supportive care.

Neural stem cells (NSCs) are a type of undifferentiated cells found in the central nervous system, including the brain and spinal cord. They have the ability to self-renew and generate the main types of cells found in the nervous system, such as neurons, astrocytes, and oligodendrocytes. NSCs are capable of dividing symmetrically to increase their own population or asymmetrically to produce one stem cell and one differentiated cell. They play a crucial role in the development and maintenance of the nervous system, and have the potential to be used in regenerative medicine and therapies for neurological disorders and injuries.

Brain neoplasms, also known as brain tumors, are abnormal growths of cells within the brain. These growths can be benign (non-cancerous) or malignant (cancerous). Benign brain tumors typically grow slowly and do not spread to other parts of the body. However, they can still cause serious problems if they press on sensitive areas of the brain. Malignant brain tumors, on the other hand, are cancerous and can grow quickly, invading surrounding brain tissue and spreading to other parts of the brain or spinal cord.

Brain neoplasms can arise from various types of cells within the brain, including glial cells (which provide support and insulation for nerve cells), neurons (nerve cells that transmit signals in the brain), and meninges (the membranes that cover the brain and spinal cord). They can also result from the spread of cancer cells from other parts of the body, known as metastatic brain tumors.

Symptoms of brain neoplasms may vary depending on their size, location, and growth rate. Common symptoms include headaches, seizures, weakness or paralysis in the limbs, difficulty with balance and coordination, changes in speech or vision, confusion, memory loss, and changes in behavior or personality.

Treatment for brain neoplasms depends on several factors, including the type, size, location, and grade of the tumor, as well as the patient's age and overall health. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. Regular follow-up care is essential to monitor for recurrence and manage any long-term effects of treatment.

Astrocytes are a type of star-shaped glial cell found in the central nervous system (CNS), including the brain and spinal cord. They play crucial roles in supporting and maintaining the health and function of neurons, which are the primary cells responsible for transmitting information in the CNS.

Some of the essential functions of astrocytes include:

1. Supporting neuronal structure and function: Astrocytes provide structural support to neurons by ensheathing them and maintaining the integrity of the blood-brain barrier, which helps regulate the entry and exit of substances into the CNS.
2. Regulating neurotransmitter levels: Astrocytes help control the levels of neurotransmitters in the synaptic cleft (the space between two neurons) by taking up excess neurotransmitters and breaking them down, thus preventing excessive or prolonged activation of neuronal receptors.
3. Providing nutrients to neurons: Astrocytes help supply energy metabolites, such as lactate, to neurons, which are essential for their survival and function.
4. Modulating synaptic activity: Through the release of various signaling molecules, astrocytes can modulate synaptic strength and plasticity, contributing to learning and memory processes.
5. Participating in immune responses: Astrocytes can respond to CNS injuries or infections by releasing pro-inflammatory cytokines and chemokines, which help recruit immune cells to the site of injury or infection.
6. Promoting neuronal survival and repair: In response to injury or disease, astrocytes can become reactive and undergo morphological changes that aid in forming a glial scar, which helps contain damage and promote tissue repair. Additionally, they release growth factors and other molecules that support the survival and regeneration of injured neurons.

Dysfunction or damage to astrocytes has been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS).

Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. It often includes hallucinations (usually hearing voices), delusions, paranoia, and disorganized speech and behavior. The onset of symptoms typically occurs in late adolescence or early adulthood. Schizophrenia is a complex, chronic condition that requires ongoing treatment and management. It significantly impairs social and occupational functioning, and it's often associated with reduced life expectancy due to comorbid medical conditions. The exact causes of schizophrenia are not fully understood, but research suggests that genetic, environmental, and neurodevelopmental factors play a role in its development.

Brain mapping is a broad term that refers to the techniques used to understand the structure and function of the brain. It involves creating maps of the various cognitive, emotional, and behavioral processes in the brain by correlating these processes with physical locations or activities within the nervous system. Brain mapping can be accomplished through a variety of methods, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET) scans, electroencephalography (EEG), and others. These techniques allow researchers to observe which areas of the brain are active during different tasks or thoughts, helping to shed light on how the brain processes information and contributes to our experiences and behaviors. Brain mapping is an important area of research in neuroscience, with potential applications in the diagnosis and treatment of neurological and psychiatric disorders.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Microglia are a type of specialized immune cell found in the brain and spinal cord. They are part of the glial family, which provide support and protection to the neurons in the central nervous system (CNS). Microglia account for about 10-15% of all cells found in the CNS.

The primary role of microglia is to constantly survey their environment and eliminate any potentially harmful agents, such as pathogens, dead cells, or protein aggregates. They do this through a process called phagocytosis, where they engulf and digest foreign particles or cellular debris. In addition to their phagocytic function, microglia also release various cytokines, chemokines, and growth factors that help regulate the immune response in the CNS, promote neuronal survival, and contribute to synaptic plasticity.

Microglia can exist in different activation states depending on the nature of the stimuli they encounter. In a resting state, microglia have a small cell body with numerous branches that are constantly monitoring their surroundings. When activated by an injury, infection, or neurodegenerative process, microglia change their morphology and phenotype, retracting their processes and adopting an amoeboid shape to migrate towards the site of damage or inflammation. Based on the type of activation, microglia can release both pro-inflammatory and anti-inflammatory factors that contribute to either neuroprotection or neurotoxicity.

Dysregulation of microglial function has been implicated in several neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and Amyotrophic Lateral Sclerosis (ALS). Therefore, understanding the role of microglia in health and disease is crucial for developing novel therapeutic strategies to treat these conditions.

The hippocampus is a complex, curved formation in the brain that resembles a seahorse (hence its name, from the Greek word "hippos" meaning horse and "kampos" meaning sea monster). It's part of the limbic system and plays crucial roles in the formation of memories, particularly long-term ones.

This region is involved in spatial navigation and cognitive maps, allowing us to recognize locations and remember how to get to them. Additionally, it's one of the first areas affected by Alzheimer's disease, which often results in memory loss as an early symptom.

Anatomically, it consists of two main parts: the Ammon's horn (or cornu ammonis) and the dentate gyrus. These structures are made up of distinct types of neurons that contribute to different aspects of learning and memory.

Computer-assisted image processing is a medical term that refers to the use of computer systems and specialized software to improve, analyze, and interpret medical images obtained through various imaging techniques such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, and others.

The process typically involves several steps, including image acquisition, enhancement, segmentation, restoration, and analysis. Image processing algorithms can be used to enhance the quality of medical images by adjusting contrast, brightness, and sharpness, as well as removing noise and artifacts that may interfere with accurate diagnosis. Segmentation techniques can be used to isolate specific regions or structures of interest within an image, allowing for more detailed analysis.

Computer-assisted image processing has numerous applications in medical imaging, including detection and characterization of lesions, tumors, and other abnormalities; assessment of organ function and morphology; and guidance of interventional procedures such as biopsies and surgeries. By automating and standardizing image analysis tasks, computer-assisted image processing can help to improve diagnostic accuracy, efficiency, and consistency, while reducing the potential for human error.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

A mental disorder is a syndrome characterized by clinically significant disturbance in an individual's cognition, emotion regulation, or behavior. It's associated with distress and/or impaired functioning in social, occupational, or other important areas of life, often leading to a decrease in quality of life. These disorders are typically persistent and can be severe and disabling. They may be related to factors such as genetics, early childhood experiences, or trauma. Examples include depression, anxiety disorders, bipolar disorder, schizophrenia, and personality disorders. It's important to note that a diagnosis should be made by a qualified mental health professional.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Magnetic Resonance Spectroscopy (MRS) is a non-invasive diagnostic technique that provides information about the biochemical composition of tissues, including their metabolic state. It is often used in conjunction with Magnetic Resonance Imaging (MRI) to analyze various metabolites within body tissues, such as the brain, heart, liver, and muscles.

During MRS, a strong magnetic field, radio waves, and a computer are used to produce detailed images and data about the concentration of specific metabolites in the targeted tissue or organ. This technique can help detect abnormalities related to energy metabolism, neurotransmitter levels, pH balance, and other biochemical processes, which can be useful for diagnosing and monitoring various medical conditions, including cancer, neurological disorders, and metabolic diseases.

There are different types of MRS, such as Proton (^1^H) MRS, Phosphorus-31 (^31^P) MRS, and Carbon-13 (^13^C) MRS, each focusing on specific elements or metabolites within the body. The choice of MRS technique depends on the clinical question being addressed and the type of information needed for diagnosis or monitoring purposes.

Brain edema is a medical condition characterized by the abnormal accumulation of fluid in the brain, leading to an increase in intracranial pressure. This can result from various causes, such as traumatic brain injury, stroke, infection, brain tumors, or inflammation. The swelling of the brain can compress vital structures, impair blood flow, and cause neurological symptoms, which may range from mild headaches to severe cognitive impairment, seizures, coma, or even death if not treated promptly and effectively.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

The brainstem is the lower part of the brain that connects to the spinal cord. It consists of the midbrain, pons, and medulla oblongata. The brainstem controls many vital functions such as heart rate, breathing, and blood pressure. It also serves as a relay center for sensory and motor information between the cerebral cortex and the rest of the body. Additionally, several cranial nerves originate from the brainstem, including those that control eye movements, facial movements, and hearing.

Brain ischemia is the medical term used to describe a reduction or interruption of blood flow to the brain, leading to a lack of oxygen and glucose delivery to brain tissue. This can result in brain damage or death of brain cells, known as infarction. Brain ischemia can be caused by various conditions such as thrombosis (blood clot formation), embolism (obstruction of a blood vessel by a foreign material), or hypoperfusion (reduced blood flow). The severity and duration of the ischemia determine the extent of brain damage. Symptoms can range from mild, such as transient ischemic attacks (TIAs or "mini-strokes"), to severe, including paralysis, speech difficulties, loss of consciousness, and even death. Immediate medical attention is required for proper diagnosis and treatment to prevent further damage and potential long-term complications.

A brain abscess is a localized collection of pus in the brain that is caused by an infection. It can develop as a result of a bacterial, fungal, or parasitic infection that spreads to the brain from another part of the body or from an infection that starts in the brain itself (such as from a head injury or surgery).

The symptoms of a brain abscess may include headache, fever, confusion, seizures, weakness or numbness on one side of the body, and changes in vision, speech, or behavior. Treatment typically involves antibiotics to treat the infection, as well as surgical drainage of the abscess to relieve pressure on the brain.

It is a serious medical condition that requires prompt diagnosis and treatment to prevent potentially life-threatening complications such as brain herniation or permanent neurological damage.

Brain hypoxia is a medical condition characterized by a reduced supply of oxygen to the brain. The brain requires a continuous supply of oxygen to function properly, and even a brief period of hypoxia can cause significant damage to brain cells.

Hypoxia can result from various conditions, such as cardiac arrest, respiratory failure, carbon monoxide poisoning, or high altitude exposure. When the brain is deprived of oxygen, it can lead to a range of symptoms, including confusion, disorientation, seizures, loss of consciousness, and ultimately, brain death.

Brain hypoxia is a medical emergency that requires immediate treatment to prevent long-term neurological damage or death. Treatment typically involves addressing the underlying cause of hypoxia, such as administering oxygen therapy, resuscitating the heart, or treating respiratory failure. In some cases, more invasive treatments, such as therapeutic hypothermia or mechanical ventilation, may be necessary to prevent further brain damage.

The cerebral cortex is the outermost layer of the brain, characterized by its intricate folded structure and wrinkled appearance. It is a region of great importance as it plays a key role in higher cognitive functions such as perception, consciousness, thought, memory, language, and attention. The cerebral cortex is divided into two hemispheres, each containing four lobes: the frontal, parietal, temporal, and occipital lobes. These areas are responsible for different functions, with some regions specializing in sensory processing while others are involved in motor control or associative functions. The cerebral cortex is composed of gray matter, which contains neuronal cell bodies, and is covered by a layer of white matter that consists mainly of myelinated nerve fibers.

Chronic brain damage is a condition characterized by long-term, persistent injury to the brain that results in cognitive, physical, and behavioral impairments. It can be caused by various factors such as trauma, hypoxia (lack of oxygen), infection, toxic exposure, or degenerative diseases. The effects of chronic brain damage may not be immediately apparent and can worsen over time, leading to significant disability and reduced quality of life.

The symptoms of chronic brain damage can vary widely depending on the severity and location of the injury. They may include:

* Cognitive impairments such as memory loss, difficulty concentrating, trouble with problem-solving and decision-making, and decreased learning ability
* Motor impairments such as weakness, tremors, poor coordination, and balance problems
* Sensory impairments such as hearing or vision loss, numbness, tingling, or altered sense of touch
* Speech and language difficulties such as aphasia (problems with understanding or producing speech) or dysarthria (slurred or slow speech)
* Behavioral changes such as irritability, mood swings, depression, anxiety, and personality changes

Chronic brain damage can be diagnosed through a combination of medical history, physical examination, neurological evaluation, and imaging studies such as MRI or CT scans. Treatment typically focuses on managing symptoms and maximizing function through rehabilitation therapies such as occupational therapy, speech therapy, and physical therapy. In some cases, medication or surgery may be necessary to address specific symptoms or underlying causes of the brain damage.

These diseases, of which there are many subtypes, are known as inborn errors of metabolism. Metabolic diseases can also occur ... The principal classes of metabolic disorders are: Acid-base imbalance Metabolic brain diseases Disorders of calcium metabolism ... Metabolic syndrome Metabolic Myopathies Lysosomal storage disease Deficiency disease Hypermetabolism "MeSH Descriptor Data: ... Fernandes, John; Saudubray, Jean-Marie; Berghe, Georges van den (2013-03-14). Inborn Metabolic Diseases: Diagnosis and ...
... brain diseases, metabolic, inborn MeSH C18.452.100.100.050 - abetalipoproteinemia MeSH C18.452.100.100.162 - carbamoyl- ... brain diseases, metabolic, inborn MeSH C18.452.648.151.050 - abetalipoproteinemia MeSH C18.452.648.151.162 - carbamoyl- ... whipple disease MeSH C18.452.648.066 - amino acid metabolism, inborn errors MeSH C18.452.648.066.102 - albinism MeSH C18.452. ... gilbert disease MeSH C18.452.648.499 - jaundice, chronic idiopathic MeSH C18.452.648.556 - lipid metabolism, inborn errors MeSH ...
... brain diseases, metabolic, inborn MeSH C16.320.565.150.050 - abetalipoproteinemia MeSH C16.320.565.150.162 - carbamoyl- ... Gilbert disease MeSH C16.320.565.499 - jaundice, chronic idiopathic MeSH C16.320.565.556 - lipid metabolism, inborn errors MeSH ... Wolman disease MeSH C16.320.565.618 - metal metabolism, inborn errors MeSH C16.320.565.618.337 - hemochromatosis MeSH C16.320. ... inborn MeSH C16.320.565.088.400 - Hartnup disease MeSH C16.320.565.088.600 - oculocerebrorenal syndrome MeSH C16.320.565.100 - ...
It also acts on the brain's cholinergic system; Amyloid β containing pyroglutamic acid is increased in Alzheimer's disease; ... as well as in certain inborn errors of metabolism, causing high anion gap metabolic acidosis. The sodium salt of pyroglutamic ... Pyroglutamic acid may function in glutamate storage, and acts to oppose the action of glutamate, including in the brain. ... Pepeu, Giancarlo; Spignoli, Giacomo (January 1989). "Nootropic drugs and brain cholinergic mechanisms". Progress in Neuro- ...
... brain death MeSH C10.228.140.163 - brain diseases, metabolic MeSH C10.228.140.163.100 - brain diseases, metabolic, inborn MeSH ... lewy body disease MeSH C10.228.140.380.615 - pick disease of the brain MeSH C10.228.140.400 - diffuse cerebral sclerosis of ... brain MeSH C10.228.140.300.510 - intracranial arterial diseases MeSH C10.228.140.300.510.200 - cerebral arterial diseases MeSH ... brain edema MeSH C10.228.140.199 - brain injuries MeSH C10.228.140.199.250 - brain concussion MeSH C10.228.140.199.250.500 - ...
Fernandes, John; Saudubray, Jean-Marie; Berghe, Georges van den; Walter, John H. (22 November 2006). Inborn Metabolic Diseases ... Carbidopa/levodopa is used to increase brain dopamine levels in the treatment of Parkinson's disease while carbidopa/oxitriptan ... Salat D, Tolosa E (January 2013). "Levodopa in the treatment of Parkinson's disease: current status and new developments". J ... Kohlstadt, Ingrid (19 April 2016). Food and Nutrients in Disease Management. CRC Press. ISBN 9781420067637. ...
November 2018). "Non-osteogenic muscle hypertrophy in children with McArdle disease". Journal of Inherited Metabolic Disease. ... De Vivo disease (GLUT1 deficiency) is a deficiency of GLUT1, which is needed to transport glucose across the blood-brain ... "Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international ... Glycogen Storage Disease Metabolic Myopathies Exercise intolerance § low ATP reservoir Myogenic hyperuricemia Purine nucleotide ...
... and trauma to the brain and spinal cord. Metabolic causes includes: glycogen storage disease type II, pyruvate dehydrogenase ... Brain malformations and inborn errors of metabolism account for 13% and 3% respectively. Causes that affects the central ... MRI Brain is used to rule out structural malformations in the brain or metabolic disorders. Magnetic resonance spectroscopic ... Prasad, Asuri N.; Prasad, Chitra (October 2003). "The floppy infant: contribution of genetic and metabolic disorders". Brain ...
Neonatal epilepsy may be credited to genetic syndromes, developmental structural brain abnormalities, or metabolic diseases. ... inborn errors of metabolism, transient metabolic and brain malformations, lead to acute symptomatic seizures. ... Seizures in the developing brain are more common than in a mature brain for several reasons. First, the developing brain is ... Further testing includes evaluation for genetic causes and other more rare metabolic causes. Brain injury such as cerebral ...
The following symptoms are reported in the literature: metabolic acidosis coma hypoglycemia seizures gastrointestinal disease ... It is speculated that an upregulation of β-oxidation also occurs in brain cells due to the hypofunctional mtFASII pathway. The ... and possibly one of the most common inborn errors of metabolism. Due to being infrequently diagnosed, it most often goes ... The metabolic Basis of Inherited Disease (5th ed.). New York. pp. 474-497.{{cite book}}: CS1 maint: location missing publisher ...
Jordaan GP, Emsley R (June 2014). "Alcohol-induced psychotic disorder: a review". Metabolic Brain Disease. 29 (2): 231-243. doi ... termed postpartum psychosis inborn errors of metabolism, such as Wilson's disease, porphyria, and homocysteinemia. nutritional ... "diseases of the mind". Hippocrates writes: Men ought to know that from the brain, and from the brain only, arise our pleasures ... and Parkinson's disease focal neurological disease, such as stroke, brain tumors, multiple sclerosis, and some forms of ...
These range from social deprivation, genetic and metabolic diseases, immune disorders, infectious diseases, nutritional factors ... For example HIV Infections of the head and brain, like brain abscesses, meningitis or encephalitis have a high risk of causing ... Two examples are diabetes mellitus (a multifactorial disorder) and phenylketonuria (an inborn error of metabolism). Many such ... Brain trauma in the developing human is a common cause (over 400,000 injuries per year in the US alone, without clear ...
Hoffmann GF, Kölker S (2016). Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. pp. 333-348. doi:10.1007/978-3-662-49771 ... Brain. 133 (Pt 7): 2148-2159. doi:10.1093/brain/awq143. PMC 2892945. PMID 20554659. Hagen J, te Brinke H, Wanders RJ, Knegt AC ... Inborn Metabolic Diseases: Diagnosis and Treatment. Berlin: Springer. p. 296. ISBN 978-3-540-28783-4. "Norwegian granted for ... It is often due to a metabolic disease in which a protein involved in the breakdown of lysine is non functional due to a ...
Toxic-metabolic encephalopathy: A catch-all for brain dysfunction caused by infection, organ failure, or intoxication. ... In modern usage, encephalopathy does not refer to a single disease, but rather to a syndrome of overall brain dysfunction; this ... Hyperammonemia: A condition caused by high levels of ammonia, which is due to inborn errors of metabolism (including urea cycle ... brain injury, or a reversible one. It can be due to direct injury to the brain, or illness remote from the brain. The ...
However, objective cognitive testing can be used to differentiate the neurocognitive deficits of brain disease from those ... hypothyroidism and Addison's disease Fibromyalgia Gulf War syndrome Heart failure HIV Inborn errors of metabolism such as ... which can produce fatigue due to inadequate nutrition Endocrine diseases or metabolic disorders: diabetes mellitus, ... heart disease, infectious diseases and post-infectious disease states. Fatigue (in the general usage sense of normal tiredness ...
... disease process, probably metabolic, which affected many of the organs and nerves in the body but affected the brain in a final ... Four types were distinguished: born criminals (inborn delinquents), pathological liars, querulous persons, and Triebmenschen ( ... In the absence of a direct physiological or genetic test or marker for each disease, it is only possible to distinguish them by ... What distinguishes each disease symptomatically (as opposed to the underlying pathology) is not any particular (pathognomonic) ...
... is a rapidly worsening brain disease. Symptoms of Reye syndrome may include vomiting, personality changes, ... Causes for similar symptoms include[citation needed] Various inborn metabolic disorders Viral encephalitis Drug overdose or ... Inborn errors of metabolism are also a risk factor. The syndrome is associated with changes on blood tests such as a high blood ... Inborn errors of metabolism are also a risk factor. The association with aspirin has been shown through epidemiological studies ...
K. Tada; N.R.M. Buist; John Fernandes; Jean-Marie Saudubray; Georges van den Berghe (March 14, 2013). Inborn Metabolic Diseases ... Metabolic crisis leading to seizures, coma, and brain damage is still a possibility. Symptoms associated with thiamine-response ... the odour of maple syrup urine disease". Journal of Inherited Metabolic Disease. 22 (2): 107-114. doi:10.1023/A:1005433516026. ... The disease is named for the presence of sweet-smelling urine, similar to maple syrup, when the person goes into metabolic ...
Journal of Inherited Metabolic Disease. 8 (2): 75-9. doi:10.1007/bf01801669. PMID 3939535. S2CID 6335599. Gray RG, Pollitt RJ, ... a rare autosomal recessive inborn error of metabolism with a highly variable phenotype. The disease is passed through autosomal ... Brain imaging showed delayed myelination and thinning of the corpus callosum. Laboratory studies showed 3-hydroxyisobutyric ... Journal of Inherited Metabolic Disease. 35 (3): 437-42. doi:10.1007/s10545-011-9381-x. PMID 21863277. S2CID 6911924. Human ...
Jakobs, C.; Jaeken, J.; Gibson, K. M. (1993). "Inherited disorders of GABA metabolism". Journal of Inherited Metabolic Disease ... The absence of SSADH leads to a 30-fold increase of GHB and a 2-4 fold increase of GABA in the brains of patients with SSADH ... Inborn errors of metabolism Chambliss, K. L.; Hinson, D. D.; Trettel, F.; Malaspina, P.; Novelletto, A.; Jakobs, C.; Gibson, K ... Such diseases are caused by an error in a single DNA gene. Because the disease is autosomal, the defective gene is found on an ...
Liu D, Zhu M, Zhang Y, Diao Y (January 2021). "Crossing the blood-brain barrier with AAV vectors". Metabolic Brain Disease. 36 ... Adachi M (1967). "Studies on Spongy Degeneration of the Central Nervous System (Van Bogaert-Bertrand Type)". Inborn Disorders ... "Aspartoacylase Deficiency (Canavan Disease) , The Online Metabolic and Molecular Bases of Inherited Disease , OMMBID , McGraw- ... Matalon RM, Michals-Matalon K (March 2000). "Spongy degeneration of the brain, Canavan disease: biochemical and molecular ...
Journal of Inherited Metabolic Disease. 40 (3): 325-342. doi:10.1007/s10545-017-0029-3. PMC 5391384. PMID 28281081. " ... Parris CR (August 2006). "An Overview of Expanded Newborn Screening for Inborn Errors of Metabolism" (PDF). Nutrition Issues in ... brain damage, and ovarian failure. Without treatment, mortality in infants with galactosemia is about 75%. Galactosemia is ... There are diseases associated with deficiencies of each of these three enzymes: The only treatment for classic galactosemia is ...
Inborn metabolic diseases diagnosis and treatment (5th ed.). Berlin: Springer. pp. 333-346. ISBN 978-3-642-15720-2. Saudubray ... Additionally, even though most mammals use the saccharopine pathway for most lysine degradation (Path 1), the brain has an ... "About Glutamate Toxicity". Huniting Disease Outreach for Education at Stanford (HOPES). Huntington's Disease Society of America ... Journal of Inherited Metabolic Disease. 1 (3): 89-94. doi:10.1007/bf01805679. PMID 116084. S2CID 35326745. Mills PB, Struys E, ...
... is a rare disease, but may be significantly underdiagnosed in people with previous traumatic brain injury. The ... In children, hypothyroidism leads to delayed growth and in extreme inborn forms to a syndrome called cretinism. Prolactin (PRL ... For instance, growth hormone deficiency is associated with obesity, raised cholesterol and the metabolic syndrome, and ... Apart from cardiovascular disease, this study also showed an increased risk of death from lung disease. Quality of life may be ...
"A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital ... Inborn error of metabolism Leukocyte adhesion deficiency PMM2 deficiency Jaeken J, Carchon H (1993). "The carbohydrate- ... Examples are the α-dystroglycanopathies (e.g. POMT1/POMT2-CDG (Walker-Warburg syndrome and Muscle-Eye-Brain syndrome)) with ... Journal of Inherited Metabolic Disease. 16 (5): 813-20. doi:10.1007/bf00714272. PMID 8295395. S2CID 10219089. Schollen, E.; ...
Journal of Inherited Metabolic Disease. 35 (2): 253-261. doi:10.1007/s10545-011-9398-1. ISSN 0141-8955. PMID 22002442. S2CID ... It can act as a neurotransmitter in the brain, act as an inhibitor in the spinal cord and brain stem, while having excitatory ... Inborn errors of metabolism, Autosomal recessive disorders, Rare diseases). ... The disease is caused by defects in the glycine cleavage system, an enzyme responsible for glycine catabolism. There are ...
An inborn error of metabolism leading to chronic metabolic acidosis". Archives of Disease in Childhood. 42 (225): 492-504. doi: ... February 2006). "Brain abnormalities in a case of malonyl-CoA decarboxylase deficiency". Molecular Genetics and Metabolism. 87 ... Journal of Inherited Metabolic Disease. 29 (2-3): 383-389. doi:10.1007/s10545-006-0278-z. PMID 16763906. S2CID 19710669. " ... 2016). Morava E, Baumgartner M, Patterson M, Rahman S (eds.). "A New Approach for Fast Metabolic Diagnostics in CMAMMA". JIMD ...
In 1963, Cockburn moved to Boston, on a Huntington-Hartford Research Foundation Fellowship in Pediatric Metabolic Disease, ... Cockburn is most notable for conducting research into fetal/neonatal nutrition and brain biochemistry, inherited metabolic ... Oxford,London : Blackwell Scientific Publications., 1974 Inborn errors of metabolism in humans : monograph based upon ... Cultured Cell and Inherited Metabolic Disease : Monograph Based Upon., R Angus Harkness; Forrester Cockburn. Dordrecht : ...
Glycogen Storage Disease Inborn Errors of Carbohydrate Metabolism Metabolic Myopathies "RCSB Protein Data Bank - Structure ... Highly similar enzymes encoded by different genes are found in liver and brain. Glycogen phosphorylase catalyses the following ... Unlike McArdle disease (GSD-V, myophosphorylase deficiency), this disease does not have exercise intolerance since ... Mutations in this gene are associated with McArdle disease (GSD-V, myophosphorylase deficiency), a glycogen storage disease of ...
A congenital metabolic disease is also referred to as an inborn error of metabolism. Most of these are single-gene defects, ... brain damage, intellectual disability, heart disease, kidney abnormality, skeletal anomalies, ocular abnormalities. The ... Different countries support the screening for a number of metabolic disorders (inborn errors of metabolism (IEM)), and genetic ... and meningoencephalitis is the enlargement of the brain. All three disorders cause abnormal brain function or intellectual ...
... recently defined inborn error of metabolism which affects the brain, gastrointestinal system and peripheral blood vessels and ... Brain Diseases, Metabolic, Inborn / diagnosis* * Brain Diseases, Metabolic, Inborn / genetics * Brain Diseases, Metabolic, ... Ethylmalonic encephalopathy (EE) is a rare, recently defined inborn error of metabolism which affects the brain, ... Brain MRI revealed bilateral and symmetrical atrophy in the fronto-temporal areas, massive enlargement of the subarachnoid ...
Genetic brain disorders affect the development and function of the brain. Some are inherited, some are caused by exposure, and ... Brain Diseases, Metabolic, Inborn (National Institutes of Health) * ClinicalTrials.gov: Niemann-Pick Diseases (National ... Wilson disease. Many people with genetic brain disorders fail to produce enough of certain proteins that influence brain ... Genetic brain disorders affect the development and function of the brain.. Some genetic brain disorders are due to random gene ...
Categories: Brain Diseases, Metabolic, Inborn Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ... The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. ... Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People ...
Metabolic Brain Diseases, Inborn + metal metabolism disorder + Methemoglobin Reductase Deficiency Methylmalonyl-Coenzyme A ... Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory ... Diseases Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental ... inborn errors ; inborn amino acid metabolism disorders ; inborn amino acidopathy ; inborn errors of amino acid metabolism ; ...
These diseases, of which there are many subtypes, are known as inborn errors of metabolism. Metabolic diseases can also occur ... The principal classes of metabolic disorders are: Acid-base imbalance Metabolic brain diseases Disorders of calcium metabolism ... Metabolic syndrome Metabolic Myopathies Lysosomal storage disease Deficiency disease Hypermetabolism "MeSH Descriptor Data: ... Fernandes, John; Saudubray, Jean-Marie; Berghe, Georges van den (2013-03-14). Inborn Metabolic Diseases: Diagnosis and ...
Brain Diseases, Metabolic, Inborn [C10.228.140.163.100]. *Lysosomal Storage Diseases, Nervous System [C10.228.140.163.100.435] ... Brain Diseases, Metabolic [C18.452.132]. *Brain Diseases, Metabolic, Inborn [C18.452.132.100]. *Lysosomal Storage Diseases, ... Genetic Diseases, Inborn [C16.320]. *Metabolism, Inborn Errors [C16.320.565]. *Brain Diseases, Metabolic, Inborn [C16.320. ... "Gaucher Disease" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ...
... including brain and spine anomaly, hyaline membrane disease prevention, congenital cystic adenomatoid malformation (CCAM), ... Fetal anomalies targeted with prenatal pharmacotherapy are a heterogeneous group of structural, endocrine, and metabolic ... congenital adrenal hyperplasia, congenital heart block, fetal tachyarrhythmia, inborn errors of metabolism, fetal thyroid ...
The 19th century saw the first systemic approach to disease through the use of rational, consistent outlines for taking ... Brain Imaging and Genetic Risk in the Pediatric Population, Part 1: Inherited Metabolic Diseases. Neuroimaging Clin N Am. 2015 ... This study placed the prevalence of inherited metabolic disorders at 1 in 784 live births. [18] About 1000 inborn errors of ... Inherited metabolic diseases: a guide to 100 conditions. Archives of Disease in Childhood. 2008 Jan. 93(1):92. ...
Vitetta, Luis, et al. "The Brain-Intestinal Mucosa-Appendix- Microbiome-Brain Loop." Diseases, vol. 6, no. 2, 2018, p. 23, doi: ... Control of Metabolic Processes. Springer Science & Business Media, 2013.. *Court, Steven J., et al. "Lower Glycolysis Carries a ... She enjoys identifying and designing nutritional intervention for subtle inborn errors of metabolism. She is also working with ... Bar-Even, Arren, et al. "Rethinking Glycolysis: On the Biochemical Logic of Metabolic Pathways." Nature Chemical Biology, vol. ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
BRAIN DISEASES, METABOLIC, INBORN ENFERMEDADES CEREBRALES METABOLICAS INNATAS DOENÇAS CEREBRAIS METABÓLICAS CONGÊNITAS ... BRAIN DISEASES, METABOLIC, ACQUIRED ENFERMEDADES CEREBRALES METABOLICAS ADQUIRIDAS DOENÇAS CEREBRAIS METABÓLICAS ADQUIRIDAS ... BRAIN INFARCTION INFARTO DEL CEREBRO INFARTO ENCEFÁLICO BRAIN INJURY, CHRONIC TRAUMATISMO CEREBRAL CRÔNICO LESÃO CEREBRAL ... BRAIN STEM INFARCTIONS INFARTOS DEL TRONCO CEREBRAL INFARTOS DO TRONCO CEREBRAL BRAIN STEM NEOPLASMS NEOPLASMAS DEL TRONCO ...
Inborn genetic diseases*Inborn errors of metabolism*Brain Diseases, Metabolic, Inborn*Disorder of the urea cycle metabolism* ... Metabolic basis and treatment of citrin deficiency.. Hayasaka K. J Inherit Metab Dis 2021 Jan;44(1):110-117. Epub 2020 Aug 26 ... Metabolic basis and treatment of citrin deficiency.. Hayasaka K. J Inherit Metab Dis 2021 Jan;44(1):110-117. Epub 2020 Aug 26 ... mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency. ...
Brain Diseases, Metabolic, Inborn. Brain Diseases, Metabolic. Brain Diseases. Central Nervous System Diseases. Nervous System ... Amino Acid Metabolism, Inborn Errors. Metabolism, Inborn Errors. Genetic Diseases, Inborn. Metabolic Diseases. Pregnancy ... Genetic and Rare Diseases Information Center resources: Phenylketonuria Inborn Amino Acid Metabolism Disorder ...
An astrogliopathy and a form of Alexander disease (AxD) characterized by ataxia, bulbar symptoms, spastic paraparesis, palatal ... Inborn genetic diseases*Inborn errors of metabolism*Brain Diseases, Metabolic, Inborn*Hereditary Central Nervous System ... Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 ... Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 ...
Brain Diseases [C10.228.140]. *Brain Diseases, Metabolic [C10.228.140.163]. *Brain Diseases, Metabolic, Inborn [C10.228.140.163 ... Brain Diseases, Metabolic [C18.452.132]. *Brain Diseases, Metabolic, Inborn [C18.452.132.100]. *Hartnup Disease [C18.452. ... "Hartnup Disease" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Hartnup Disease" by people in this website by year, and ...
Keywords: Hepatolenticular Degeneration, Delusions, Mental Disorders, Brain Diseases, Metabolic, Inborn; Figure & Data. ... Case report A Case of Willson Disease with Grandiose Delusion Ho Chan Kim, Chang Young Lee, Dong Won Oh 과대망상을 보이는 Wilson씨 병 사례 ...
Acquired Metabolic Diseases, Brain -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain ... Acquired Metabolic Diseases, Nervous System -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce ... Acquired Metabolic Encephalopathies -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain ... Acquired Metabolic Encephalopathy -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain ...
Acquired Metabolic Diseases, Brain -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain ... Acquired Metabolic Diseases, Nervous System -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce ... Acquired Metabolic Encephalopathies -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain ... Acquired Metabolic Encephalopathy -- See Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain ...

No FAQ available that match "brain diseases metabolic inborn"

No images available that match "brain diseases metabolic inborn"